Toshihiro Shioda

Massachusetts General Hospital

NIH Rank #5583
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#5,583
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 6 grants · National rank #5583.

Top grants by award amount

Toshihiro Shioda's NIH grant portfolio, ranked by award amount.

  • 5R01ES023316-12R01
    Chromatin contacts are germline-transmissable vehicles underlying epigenetic transgenerational inheritance
    $640.1K
    award amount
  • 1R01ES035401-01A1R01
    Environmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivation
    $620.9K
    award amount
  • 1R21DA059789-01R21
    Cannabinoids as an environmental risk factor of testicular cancer: Assessment using cell culture models of human and mouse primordial germ cells and by exposure of pregnant mice
    $264.8K
    award amount
  • 5R21ES034468-02R21
    Applications of the long-term culture human primordial germ cell-like cells to toxicological assessments and mechanistic studies on chemically caused heritable human health threats
    $208.8K
    award amount
  • 5R21HD110839-02R21
    Roles of the LTR5_Hs human-specific endogenous retroviruses in primordial germ cells
    $208.8K
    award amount
  • 3R01ES031139-04S1R01
    Interactions between prenatal obesogen exposure and Total Western diet lead to a transgenerational thrifty phenotype: functional and epigenomic analysis of effects in fat and liver
    $13K
    award amount

Affiliations

Institutions that have administered grants for Toshihiro Shioda.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5583
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions